Artificial Saliva Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Artificial Saliva Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The Artificial Saliva Market is poised for significant growth, driven by a surge in per capita spending on oral care products. According to data from the World Health Organization, oral diseases rank as the fourth-most expensive diseases to treat globally, affecting both emerging and developed economies. The growing expenditure on oral health maintenance has a direct impact on the artificial saliva market.

Key Drivers:
• Increase in Disposable Income: The artificial saliva market, being consumer-based, is expected to witness growth with an increase in disposable income and per capita spending. As individuals allocate more resources to oral care, the demand for artificial saliva products is likely to rise steadily.
• Dysphagia Prevention: Studies have demonstrated the effectiveness of artificial saliva products in reducing dysphagia symptoms among patients undergoing cancer treatment. With aging populations in regions like Europe, North America, and Japan, the market for dysphagia supplements presents a lucrative opportunity for the artificial saliva market.
• Preference for Oral Gels and Liquids: Within the artificial saliva market, oral gels and oral liquids are favored due to their ease of use. These products promote compliance, as they are associated with oral hygiene, unlike tablets, which may have lower compliance rates due to their medicinal connotations. Among these, oral liquids hold greater potential as a key segment.
• Dominance of Oral Sprays: The oral sprays segment currently commands the highest revenue share in the artificial saliva market and is expected to maintain its lead throughout the forecast period. Oral sprays are preferred for their convenience and affordability.

Challenges Ahead:
• Availability of Alternatives: The artificial saliva market faces competition from alternative treatments for dry mouth, including herbal medicines, acupuncture, and salivary stimulants. These alternatives pose a challenge to the unencumbered growth of the artificial saliva market. Additionally, ongoing research and development efforts to develop artificial salivary glands for individuals with salivary gland damage and the emergence of saliva stimulating pens further complicate the market landscape.

Competitive Analysis:

Key Companies Profiled
• GlaxoSmithKline plc
• Cipla Limited
• Mission Pharmacal Company
• Fresenius Kabi
• Parnell Pharmaceuticals, Inc.
• CCMed Group
• Entod International
• Midatech Pharma Plc.
• Forward Science
• Valeant Pharmaceuticals International, Inc.
• Biocosmetics Laboratories
• Icpa Health Products Ltd.
• Perrigo
• Laboratorios Kin, S.A.

Artificial Saliva Market Segmentation

Product Type
• Oral Spray
• Oral Solution
• Oral Liquid
• Gel
• Powder

Age Group
• Adult
• Paediatric

Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Mail Order Pharmacies
• Hypermarkets and Supermarkets

Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East and Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.